Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gait and six-minute walk performance in persons with multiple sclerosis.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.
Neuromyelitis optica in child: diagnostic and therapeutic challenges.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Brain atrophy at onset and physical disability in multiple sclerosis.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Danish translation and psychometric testing of the Rivermead Mobility Index.
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Management of faecal incontinence and constipation in adults with central neurological diseases.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain.
Pages
« first
‹ previous
…
303
304
305
306
307
308
309
310
311
…
next ›
last »